GR1801

GR1801 · Genrix (Shanghai) Biopharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GR1801, covering 2024-09-25 to 2024-09-25. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate GR1801's Efficacy and Safety [Phase 3]